Cargando…
Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations https://bit.ly/38UnuRW
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291932/ https://www.ncbi.nlm.nih.gov/pubmed/34295395 http://dx.doi.org/10.1183/20734735.0279-2020 |
_version_ | 1783724744039727104 |
---|---|
author | Ojanguren, Iñigo Pilia, María Florencia |
author_facet | Ojanguren, Iñigo Pilia, María Florencia |
author_sort | Ojanguren, Iñigo |
collection | PubMed |
description | Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations https://bit.ly/38UnuRW |
format | Online Article Text |
id | pubmed-8291932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-82919322021-07-21 Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial Ojanguren, Iñigo Pilia, María Florencia Breathe (Sheff) Expert Opinion Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations https://bit.ly/38UnuRW European Respiratory Society 2021-03 /pmc/articles/PMC8291932/ /pubmed/34295395 http://dx.doi.org/10.1183/20734735.0279-2020 Text en Copyright ©ERS 2021 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Expert Opinion Ojanguren, Iñigo Pilia, María Florencia Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title | Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title_full | Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title_fullStr | Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title_full_unstemmed | Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title_short | Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial |
title_sort | efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the captain trial |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291932/ https://www.ncbi.nlm.nih.gov/pubmed/34295395 http://dx.doi.org/10.1183/20734735.0279-2020 |
work_keys_str_mv | AT ojangureninigo efficacyandsafetyofoncedailysingleinhalertripletherapyinpatientswithinadequatelycontrolledasthmathecaptaintrial AT piliamariaflorencia efficacyandsafetyofoncedailysingleinhalertripletherapyinpatientswithinadequatelycontrolledasthmathecaptaintrial |